Olivier L. Windisch
Geneve, GE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Urology. Quality of life and safety : the new promises
Journal: Revue medicale suisse
Published: January 16, 2026
Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsy in the Era of Lesion-focused Sampling.
Journal: European urology focus
Published: November 23, 2025
Targeted, Perilesional, and Distant Biopsies in Prostate Cancer.
Journal: European urology oncology
Published: November 02, 2025
Confirmatory MRI and re-biopsy findings during active surveillance in patients with grade group 2 prostate cancer.
Journal: Actas urologicas espanolas
Published: October 12, 2025
Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging-targeted prostate biopsy grade groups are discordant.
Journal: Journal of the National Cancer Institute
Published: February 21, 2025
Standardizing targeted and perilesional biopsy: considerations and challenges.
Journal: Prostate cancer and prostatic diseases
Published: February 03, 2025
With great power comes great risk: High ureteral stricture rate after high-power, high-frequency Thulium fiber laser lithotripsy in ureteroscopy.
Journal: World journal of urology
Published: January 29, 2025
Are Patients with Prostate Imaging Reporting and Data System 5 Lesions Eligible for Active Surveillance? A Multicentric European Study.
Journal: European urology oncology
Published: November 26, 2024
Gleason pattern 4 and active surveillance in patients with grade group 2 prostate cancer.
Journal: Prostate cancer and prostatic diseases
Published: November 18, 2024
Active Surveillance of Grade Group 2 Prostate Cancer: Oncological Outcomes from a Contemporary European Cohort.
Journal: European urology oncology
Published: November 05, 2024
Biopsy strategies in the era of mpMRI: a comprehensive review.
Journal: Prostate cancer and prostatic diseases
Published: June 13, 2024
Refining clinically relevant cut-offs of prostate specific antigen density for risk stratification in patients with PI-RADS 3 lesions.
Journal: Prostate cancer and prostatic diseases
Published: May 19, 2024
Last Updated: 09/26/2026